H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Balchem (NASDAQ:BCPC) Corp. on Monday, setting a price target of $126, which is approximately 21.38% above the present share price of $103.81.
Selvaraju expects Balchem Corp . to post earnings per share (EPS) of $0.67 for the fourth quarter of 2020.
The current consensus among 1 TipRanks analysts is for a Moderate Buy rating of shares in Balchem, with an average price target of $126.
The analysts price targets range from a high of $126 to a low of $126.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $175.14 million and a net profit of $29.03 million. The company's market cap is $3.36 billion.
According to TipRanks.com, H.C. Wainwright analyst Ram Selvaraju is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 18.4% and a 57.34% success rate.
marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in New Hampton, NY.